Business Combination - Schedule of Intangible Assets Acquired (Details) - Convergent Genomics, Inc. $ in Thousands |
Sep. 14, 2026
USD ($)
|
|---|---|
| Acquired Indefinite-lived Intangible Assets [Line Items] | |
| Fair Value | $ 96,880 |
| Developed technology | |
| Acquired Indefinite-lived Intangible Assets [Line Items] | |
| Fair Value | $ 95,900 |
| Estimated Useful Life | 15 years |
| Trademarks and tradenames | |
| Acquired Indefinite-lived Intangible Assets [Line Items] | |
| Fair Value | $ 60 |
| Estimated Useful Life | 5 years |
| Customer relationships | |
| Acquired Indefinite-lived Intangible Assets [Line Items] | |
| Fair Value | $ 920 |
| Estimated Useful Life | 5 years |